Results 141 to 150 of about 21,470 (167)

Erythrocytes as immunomodulators in trauma: orchestrating clearance pathways, inflammation, and organ injury. [PDF]

Front Immunol
Qian X, Chen L, Gao R, Lin Y, Wu K, Wang X, Jiang Y.   +6 more
europepmc   +1 more source

Multiple genetic engineering of porcine red blood cells improves compatibility with human blood. [PDF]

iScience
Lu P, Wang Y, Du J, Yan J, Deng S, He D, Ren Z, Dai Z, Li D, Pan D.   +9 more
europepmc   +1 more source

Tumor-associated protease-activated anti-CD47 antibody precisely maintains phagocytic ability of macrophages with minimal effect on healthy tissue. [PDF]

J Transl Med
Chen YT, Jhuang ZY, Li PJ, Lu YC, Huang BC, Chang CY, Su YC, Chuang CH, Cheng TL, Chen FM, Lin SY, Huang HK, Lin WW.   +12 more
europepmc   +1 more source

Myeloid Malignancies Beyond the Cell: Targeting the Tumour Microenvironment with Next-Generation Immunotherapies. [PDF]

Cancers (Basel)
Amirian N, Squires A, Azanabor L, Walker CL, Simmonds MJ, Rinaldi C.   +5 more
europepmc   +1 more source

Irinotecan Modulates Immune Checkpoints in Neuroblastoma. [PDF]

Immunotargets Ther
Lapidus T, Zorde-Khvalevsky E, Jolani A, Goldstein G, Peled A.   +4 more
europepmc   +1 more source

Quantitative detection of macrophage activation in osteosarcoma comparing ¹⁸F-FDG PET/CT with ferumoxytol-enhanced MRI. [PDF]

Sci Rep
Roudi R, Habte F, Saladino GM, Vasyliv I, Pisani L, Wong J, Syed A, Daldrup-Link HE.   +7 more
europepmc   +1 more source

Analysis of Prognostic Significance of CD47 Expression in Newly Diagnosed Large B Cell Lymphoma. [PDF]

Life (Basel)
Markovic O, Bukurecki I, Divac Pravdic A, Marinkovic G, Terzic T, Pavlovic M, Nikolic V, Vukosavljevic N, Cvetkovic Z.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

A bispecific antibody targeting GPC3 and CD47 induced enhanced antitumor efficacy against dual antigen-expressing HCC

Molecular Therapy, 2021
Jianhua Sui, Yulu Li, Yonghe Qi
exaly